SRBK vs UTHR · P/E 33, rev $46.3M vs P/E 20, rev $1.56B
SR Bancorp, Inc. Common stock (SRBK) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
SR Bancorp, Inc. Common stock (SRBK) is a banks - regional company listed on NASDAQ.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported SRBK revenue for 2025-06-30 was $46.3M. Net income was $5.1M. Revenue was up 13.3% from 2024-06-30 to 2025-06-30. SRBK currently screens at market cap $140.4M and trailing P/E 32.6.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
SRBK currently screens at market cap $140.4M and trailing P/E 32.6. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the SRBK and UTHR stock pages for the full models.
Not investment advice.